X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ABBOTT INDIA - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ABBOTT INDIA BIOCON /
ABBOTT INDIA
 
P/E (TTM) x 41.0 38.0 108.1% View Chart
P/BV x 7.1 9.8 72.7% View Chart
Dividend Yield % 0.2 0.7 23.1%  

Financials

 BIOCON    ABBOTT INDIA
EQUITY SHARE DATA
    BIOCON
Mar-18
ABBOTT INDIA
Mar-18
BIOCON /
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,1886,110 19.4%   
Low Rs3053,996 7.6%   
Sales per share (Unadj.) Rs68.71,552.2 4.4%  
Earnings per share (Unadj.) Rs7.6188.8 4.0%  
Cash flow per share (Unadj.) Rs14.0196.4 7.1%  
Dividends per share (Unadj.) Rs1.0055.00 1.8%  
Dividend yield (eoy) %0.11.1 12.3%  
Book value per share (Unadj.) Rs86.3796.6 10.8%  
Shares outstanding (eoy) m600.0021.25 2,823.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.93.3 333.7%   
Avg P/E ratio x98.926.8 369.4%  
P/CF ratio (eoy) x53.425.7 207.7%  
Price / Book Value ratio x8.66.3 136.3%  
Dividend payout %13.229.1 45.5%   
Avg Mkt Cap Rs m447,900107,376 417.1%   
No. of employees `0006.13.3 185.1%   
Total wages/salary Rs m9,3113,937 236.5%   
Avg. sales/employee Rs Th6,705.89,929.3 67.5%   
Avg. wages/employee Rs Th1,514.21,185.1 127.8%   
Avg. net profit/employee Rs Th736.91,207.7 61.0%   
INCOME DATA
Net Sales Rs m41,23432,985 125.0%  
Other income Rs m2,0621,170 176.3%   
Total revenues Rs m43,29634,155 126.8%   
Gross profit Rs m8,2915,245 158.1%  
Depreciation Rs m3,851162 2,378.6%   
Interest Rs m61538 1,609.9%   
Profit before tax Rs m5,8876,215 94.7%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5692,203 71.2%   
Profit after tax Rs m4,5314,012 112.9%  
Gross profit margin %20.115.9 126.5%  
Effective tax rate %26.735.4 75.2%   
Net profit margin %11.012.2 90.3%  
BALANCE SHEET DATA
Current assets Rs m41,48622,655 183.1%   
Current liabilities Rs m21,4136,681 320.5%   
Net working cap to sales %48.748.4 100.5%  
Current ratio x1.93.4 57.1%  
Inventory Days Days6465 98.7%  
Debtors Days Days9429 323.1%  
Net fixed assets Rs m50,661835 6,063.8%   
Share capital Rs m3,000213 1,411.8%   
"Free" reserves Rs m48,80816,715 292.0%   
Net worth Rs m51,80816,928 306.1%   
Long term debt Rs m17,8980-   
Total assets Rs m99,89724,162 413.4%  
Interest coverage x10.6163.7 6.5%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.41.4 30.2%   
Return on assets %5.216.8 30.7%  
Return on equity %8.723.7 36.9%  
Return on capital %9.636.9 26.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,058369 3,271.8%   
Fx outflow Rs m7,3483,807 193.0%   
Net fx Rs m4,710-3,438 -137.0%   
CASH FLOW
From Operations Rs m6,6211,527 433.6%  
From Investments Rs m-6,840-2,148 318.4%  
From Financial Activity Rs m-2,397-1,024 234.0%  
Net Cashflow Rs m-2,612-1,646 158.7%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.6 75.0 27.5%  
Indian inst/Mut Fund % 8.4 7.9 106.3%  
FIIs % 10.7 0.1 10,700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 17.1 116.4%  
Shareholders   109,995 18,270 602.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  STRIDES PHARMA SCIENCE  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 18, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS